Ghent University Academic Bibliography

Your filters: cql: author="Schots, Rik" or (type any "bookEditor issueEditor" and editor="Schots, Rik")

Add to list
- Journal Article
- A1
- open access
Palliative care in hematology : a systematic review of the components, effectiveness, and implementation

Sophie Hochrath (UGent) , Naomi Dhollander (UGent) , Luc Deliens (UGent) , Rik Schots, Frederick Daenen (UGent) , Tessa Kerre (UGent) , Kim Beernaert (UGent) and Koen Pardon (UGent)

(2025) JOURNAL OF PAIN AND SYMPTOM MANAGEMENT. 69(1). p.114-133.e2
Add to list
Feasibility of co-transplantation of umbilical cord blood and third-party mesenchymal stromal cells after (non)myeloablative conditioning in patients with hematological malignancies

Simon Planken, Ann De Becker, Tessa Kerre (UGent) , Helene Schoemans, Frederic Barond, Carlos Graux, Ivan Van Riet, Chantal Lechanteur, Etienne Baudoux, Rik Schots, et al.

(2024) CURRENT RESEARCH IN TRANSLATIONAL MEDICINE. 72(4).
Add to list
- Conference Paper
- C3
Real life management of antibiotic therapy in HSCT recipients : focus on de-escalation in pre-engraftment neutropenia, the study from the EBMT infectious diseases working party (IDWP)

Malgorzata Mikulska, Lotus Wendel, Gloria Tridello, Alexander Kulagin, Anna Czyz, Nabil Yafour, Fabio Ciceri, Burak Deveci, Simona Sica, Kristina Carlson, et al.

(2024) BONE MARROW TRANSPLANTATION. In Bone Marrow Transplantation 59(Supplement 1). p.456-457
Add to list
- Journal Article
- A1
- open access
The transfer of sphingomyelinase contributes to drug resistance in multiple myeloma

Sylvia Faict, Inge Oudaert, Ludovic D'Auria, Jonas Dehairs, Ken Maes, Philip Vlummens, Kim De Veirman, Elke De Bruyne, Karel Fostier, Isabelle Vande Broek, et al.

(2019) CANCERS. 11(12).
Add to list
- Conference Paper
- C3
The exosomal transfer of acid sphingomyelinase contributes to drug resistance in multiple myeloma

Inge Oudaert, Sylvia Faict, Ludovic D'Auria, Jonas Dehairs, Ken Maes, Philip Vlummens, Lotte Jacobs, Kim De Veirman, Elke De Bruyne, Karel Fostier, et al.

(2019) BLOOD. 134.
Add to list
- Conference Paper
- C3
Multipotent mesenchymal stromal cells for poor graft function after allogeneic hematopoietic cell transplantation : a multicenter prospective study

Sophie Servais, Frederic Baron, Chantal Lechanteur, Etienne Baudoux, Alexandra Briquet, Dominik Selleslag, Johan A. Maertens, Xavier Poire, Wilfried Schroyens, Carlos Graux, et al.

(2019) BLOOD. 134(Suppl 1).
Add to list
End-of-life decision-making across cancer types : results from a nationwide retrospective survey among treating physicians

Mariëtte N Verkissen, Dirk Houttekier, Joachim Cohen, Rik Schots, Kenneth Chambaere (UGent) and Luc Deliens (UGent)

(2018) BRITISH JOURNAL OF CANCER. 118. p.1369-1376
Add to list
- Journal Article
- A1
- open access
Preclinical evaluation of invariant natural killer T cells in the 5T33 multiple myeloma model

Haneen Nur, Karel Fostier, SANDRINE ASPESLAGH (UGent) , Wim Renmans, Elisabeth Bertrand, Xavier Leleu, Mérédis Favreau (UGent) , Karine Breckpot, Rik Schots, Marc De Waele, et al.

(2013) PLOS ONE. 8(5).
Add to list
Role of the inhibitory KIR ligand HLA-Bw4 and HLA-C expression levels in the recognition of leukemic cells by Natural Killer cells.

Sonja Verheyden, Soldano Ferrone, Arend Mulder, Frans Claas, Rik Schots, Barbara De Moerloose (UGent) , Yves Benoit and Christian Demanet

(2009) CANCER IMMUNOLOGY IMMUNOTHERAPY. 58(6). p.855-865

Academic Bibliography

Palliative care in hematology : a systematic review of the components, effectiveness, and implementation

Feasibility of co-transplantation of umbilical cord blood and third-party mesenchymal stromal cells after (non)myeloablative conditioning in patients with hematological malignancies

Real life management of antibiotic therapy in HSCT recipients : focus on de-escalation in pre-engraftment neutropenia, the study from the EBMT infectious diseases working party (IDWP)

The transfer of sphingomyelinase contributes to drug resistance in multiple myeloma

The exosomal transfer of acid sphingomyelinase contributes to drug resistance in multiple myeloma

Multipotent mesenchymal stromal cells for poor graft function after allogeneic hematopoietic cell transplantation : a multicenter prospective study

End-of-life decision-making across cancer types : results from a nationwide retrospective survey among treating physicians

Preclinical evaluation of invariant natural killer T cells in the 5T33 multiple myeloma model

Role of the inhibitory KIR ligand HLA-Bw4 and HLA-C expression levels in the recognition of leukemic cells by Natural Killer cells.

Contents

Support

Contact